GlassScriptPhysician profile
Yocoima S Plaza
NPI 1861771008
$16,434.32
in general payments reported to CMS, 2019-2025
42 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,179 · 2020: $643 · 2021: $1,158 · 2022: $1,715 · 2023: $1,654 · 2024: $967 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,418 · Education: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,417.52 |
| Education | $322.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,319.33 | 2019-2020 | |
| Kvk-Tech, INC. | $1,017.80 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $683.00 | 2021-2025 | |
| Astellas Pharma US INC | $634.19 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $602.99 | 2019-2023 | |
| Myovant Sciences INC. | $504.70 | 2021-2022 | |
| Exeltis, USA INC. | $445.79 | 2019-2025 | Slynd, Tyblume |
| Therapeuticsmd, INC. | $439.91 | 2019-2022 | |
| Novo Nordisk INC | $417.83 | 2019-2024 | Wegovy |
| Sumitomo Pharma America, INC. | $392.24 | 2023-2025 | Myfembree, Gemtesa |
| Cumberland Pharmaceuticals, INC. | $314.65 | 2019-2023 | Kristalose |
| Hologic Sales and Service, LLC | $281.93 | 2021-2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Lupin INC. | $275.41 | 2019-2021 | |
| Millicent US INC | $273.60 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $266.56 | 2019-2023 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $241.86 | 2022 | |
| Biogen, INC. | $236.05 | 2024-2025 | Zurzuvae |
| Radius Health, INC. | $235.40 | 2021-2024 | Tymlos |
| Amgen INC. | $214.44 | 2019-2025 | Evenity |
| Vertex Pharmaceuticals Incorporated | $213.55 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $169.56 | 2019-2025 | |
| Organon LLC | $131.68 | 2022-2024 | Nexplanon |
| Exact Sciences Corporation | $129.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medical Device Business Services, INC. | $124.99 | 2022 | |
| Agile Therapeutics, INC. | $113.16 | 2021-2024 | Twirla |
| Duchesnay USA Incorporated | $79.89 | 2019 | |
| Merck Sharp & Dohme LLC | $77.78 | 2019-2023 | Gardasil 9 |
| Allergan, INC. | $76.59 | 2019-2020 | |
| Avion Pharmaceuticals | $64.83 | 2019-2023 | Balcoltra |
| Coopersurgical, INC. | $59.04 | 2022-2024 | Summit Doppler |
| Vivus LLC | $53.84 | 2019-2022 | |
| Channel Medsystems, INC. | $44.50 | 2023-2025 | |
| Shield Therapeutics INC | $43.66 | 2022-2023 | Accrufer |
| Scynexis, INC. | $41.52 | 2022 | |
| Ascend Therapeutics US, LLC | $38.46 | 2021-2022 | |
| Lilly USA, LLC | $32.97 | 2024-2025 | Zepbound, Jardiance |
| Mylan Pharmaceuticals INC. | $30.98 | 2021 | |
| Amag Pharmaceuticals, INC. | $29.31 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.84 | 2019 | |
| Sage Therapeutics, LLC | $19.24 | 2021 | |
| Avanos Medical | $17.03 | 2019 | |
| Baxter Healthcare | $16.48 | 2025 | Perclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yocoima Plaza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.